Icon

ICOTYDE (NDA220149)- (EQ 200MG BASE)

ICOTROKINRA HYDROCHLORIDE JANSSEN BIOTECH
EQ 200MG BASE
No No
2041-Nov-19 2031-Mar-17
None None
None No
ICOTYDE is an interleukin-23 (IL-23) receptor antagonist indicated for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age and older who weigh at least 40 kg who are candidates for systemic therapy or phototherapy.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 200MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.